Sintx Technologies (SINT) Revenue Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 4.63% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 8.01% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 5.28% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 15.36% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 10.52% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 0.73% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 17.14% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 2.92% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 7.43% |
| 10 | Sintx Technologies | 8.71 Mn | 6.82 Mn | 144,000.00 | -11.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -11.00% |
| Dec 31, 2025 | -27.63% |
| Sep 30, 2025 | -21.26% |
| Jun 30, 2025 | -14.31% |
| Mar 31, 2025 | 41.95% |
| Dec 31, 2024 | 48.65% |
| Sep 30, 2024 | 49.53% |
| Jun 30, 2024 | 104.12% |
| Mar 31, 2024 | 89.47% |
| Dec 31, 2023 | 98.11% |
| Sep 30, 2023 | 117.38% |
| Jun 30, 2023 | 35.54% |
| Mar 31, 2023 | 37.57% |
| Dec 31, 2022 | 44.80% |
| Sep 30, 2022 | 35.04% |
| Jun 30, 2022 | 12.85% |
| Mar 31, 2022 | 9.97% |
| Jun 30, 2021 | -63.27% |
| Mar 31, 2021 | -64.67% |
| Dec 31, 2020 | -63.74% |
| Sep 30, 2020 | -71.84% |
| Jun 30, 2020 | -60.09% |
| Mar 31, 2020 | -57.14% |
| Dec 31, 2019 | -58.98% |
| Sep 30, 2019 | -62.86% |
| Jun 30, 2019 | -65.38% |
| Mar 31, 2019 | -71.46% |
| Jun 30, 2018 | -24.72% |
| Mar 31, 2018 | -21.54% |
| Dec 31, 2017 | -22.11% |
| Sep 30, 2017 | -21.01% |
| Jun 30, 2017 | -18.08% |
| Mar 31, 2017 | -23.10% |
| Dec 31, 2016 | -13.84% |
| Sep 30, 2016 | -13.93% |
| Jun 30, 2016 | -12.73% |
| Mar 31, 2016 | -7.39% |